Biofrontera Inc.
Pharmaceutical company · Woburn, Massachusetts, United States · Nasdaq: BFRI
Biofrontera Inc. is a pharmaceutical company headquartered in Woburn, Massachusetts, United States. Its shares trade on Nasdaq under the ticker BFRI. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2025.
Biofrontera at a glance
What does Biofrontera do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $11 million sold (2025).
Frequently asked questions about Biofrontera
Where is Biofrontera headquartered?
Biofrontera Inc. is headquartered in Woburn, Massachusetts, United States.
What does Biofrontera do?
Biofrontera Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Biofrontera a public company?
Yes. Biofrontera Inc. trades on Nasdaq under the ticker BFRI.
Similar companies
- Rational Vaccines, Inc.Woburn, Massachusetts, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.